Serotype-dependent recombinant adeno-associated vector (AAV) infection of Epstein–Barr virus-positive B-cells, towards recombinant AAV-based therapy of focal EBV + lymphoproliferative disorders

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1743-422X
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Serotype-dependent recombinant adeno-associated vector (AAV) infection of Epstein–Barr virus-positive B-cells, towards recombinant AAV-based therapy of focal EBV + lymphoproliferative disorders ; volume:18 ; number:1 ; day:18 ; month:11 ; year:2021 ; pages:1-12 ; date:12.2021
Virology journal ; 18, Heft 1 (18.11.2021), 1-12, 12.2021

Creator
Ahmadi, Elham
Ravanshad, Mehrdad
Xie, Jun
Panigrahi, Rajesh
Jubbal, Sandeep S.
Guru, Santosh Kumar
Guangping, Gao
Ziyaeyan, Mazyar
Fingeroth, Joyce
Contributor
SpringerLink (Online service)

DOI
10.1186/s12985-021-01695-w
URN
urn:nbn:de:101:1-2022012819560874276273
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:20 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Ahmadi, Elham
  • Ravanshad, Mehrdad
  • Xie, Jun
  • Panigrahi, Rajesh
  • Jubbal, Sandeep S.
  • Guru, Santosh Kumar
  • Guangping, Gao
  • Ziyaeyan, Mazyar
  • Fingeroth, Joyce
  • SpringerLink (Online service)

Other Objects (12)

Molecular design for recombinant adeno-associated virus (rAAV) vector production

Molecular design for recombinant adeno-associated virus (rAAV) vector production

Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer

Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer

Molecular design of controllable recombinant adeno‐associated virus (AAV) expression systems for enhanced vector production

Molecular design of controllable recombinant adeno‐associated virus (AAV) expression systems for enhanced vector production

Enhanced recombinant adeno-associated virus (rAAV) in vivo transduction efficacy via surface modified PAMAM nanoparticles precoating

Hochschulschrift

Enhanced recombinant adeno-associated virus (rAAV) in vivo transduction efficacy via surface modified PAMAM nanoparticles precoating

Recombinant AAV Vectors for Enhanced Expression of Authentic IgG

Recombinant AAV Vectors for Enhanced Expression of Authentic IgG

Adeno-Associated Virus (AAV) vectors in gene therapy

Aufsatzsammlung

Adeno-Associated Virus (AAV) vectors in gene therapy

Pilot-scale process development for recombinant adeno-associated virus (rAAV) production based on high-density Sf9 cell culture

Pilot-scale process development for recombinant adeno-associated virus (rAAV) production based on high-density Sf9 cell culture

Adeno‐associated virus (AAV)-based gene therapy for glioblastoma

Adeno‐associated virus (AAV)-based gene therapy for glioblastoma

Production of recombinant AAV vectors encoding insulin-like growth factor I is enhanced by interaction among AAV rep regulatory sequences

Production of recombinant AAV vectors encoding insulin-like growth factor I is enhanced by interaction among AAV rep regulatory sequences

Adeno-Associated Virus (AAV) as a Vector for Gene Therapy

Adeno-Associated Virus (AAV) as a Vector for Gene Therapy

AAV-Jahresbericht

Bericht | Online-Publikation | Zeitschrift

AAV-Jahresbericht

Small but increasingly mighty: new insights into Adeno-associated virus (AAV) capsid biology and implications for AAV vector optimization

Hochschulschrift

Small but increasingly mighty: new insights into Adeno-associated virus (AAV) capsid biology and implications for AAV vector optimization

Related objects